about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...
Read More
5.74
1.15
(25.05%)
22.4M
XNAS Volume
High volume+gain today
XNAS 02 Sep, 2025 1:59 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..